Loewy Caroline M
Insider CIK 1367451 · CBAY Director · PHAS Director · ZGNX Director · LWAC Director · PBAX Director · APTO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-06-13 | 2024-06-13 | 800 | — | $0 | 800 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 16,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 27,705 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 49,245 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 32,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 7,500 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 15,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 30,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 67,000 | — | $0 | 0 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2024-02-19 | 2024-02-21 | 2,000 | — | $0 | 2,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-16 | 5,828 | — | $0 | 5,828 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2023-09-09 | 2023-09-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2023-05-19 | 2023-05-19 | 3,750 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2023-05-19 | 2023-05-19 | 3,750 | — | $0 | 3,750 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-01-25 | 2023-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 3,750 | — | $0 | 3,750 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 22,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 67,000 | — | $0 | 67,000 | SEC↗ |
| APTO Aptose Biosciences Inc. | A Award deriv | 2022-01-18 | 2022-01-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PBAX PHOENIX BIOTECH ACQUISITIO | J Other deriv | 2021-10-08 | 2021-10-12 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2021-06-03 | 2021-06-04 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2021-05-27 | 2021-05-28 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 32,000 | — | $0 | 32,000 | SEC↗ |
| LWAC Locust Walk Acquisition Co | J Other deriv | 2021-01-12 | 2021-01-14 | 17,500 | — | $0 | 17,500 | SEC↗ |
| APTO Aptose Biosciences Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2020-09-21 | 2020-09-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2020-06-03 | 2020-06-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 49,245 | — | $0 | 49,245 | SEC↗ |
| APTO Aptose Biosciences Inc. | A Award deriv | 2020-03-11 | 2020-03-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| APTO Aptose Biosciences Inc. | A Award deriv | 2020-03-11 | 2020-03-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| APTO Aptose Biosciences Inc. | A Award deriv | 2020-01-31 | 2020-02-03 | 65,000 | — | $0 | 65,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-05-09 | 2019-05-13 | 9,167 | — | $0 | 9,167 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-02-27 | 2019-03-01 | 8,900 | — | $0 | 8,900 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2019-01-29 | 2019-01-31 | 27,705 | — | $0 | 27,705 | SEC↗ |
| APTO Aptose Biosciences Inc. | A Award deriv | 2019-01-02 | 2019-01-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-09-22 | 2017-09-26 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-06-28 | 2017-06-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-01-19 | 2017-01-23 | 30,000 | — | $0 | 30,000 | SEC↗ |